glucagon like peptide 1 - Robuta Search

https://pmc.ncbi.nlm.nih.gov/articles/PMC11855704/ Focus on Glucagon-like Peptide-1 Target: Drugs Approved or Designed to Treat Obesity - PMC Obesity is closely related to metabolic diseases, which brings a heavy burden to the health care system. It is urgent to formulate and implement effective... glucagon like peptide 1 https://www.jci.org/articles/view/15595/table/1 JCI - Glucagon-like peptide-1 receptor stimulation increases blood pressure and heart rate and... glucagon like peptide 1 https://pmc.ncbi.nlm.nih.gov/articles/PMC10423473/ Glucagon-like peptide-1 receptor agonists as a disease-modifying therapy for knee osteoarthritis... Obesity is a risk factor for knee osteoarthritis (KOA) development and progression. Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are indicated for type... glucagon like peptide 1 https://pmc.ncbi.nlm.nih.gov/articles/PMC10801460/ The Impact of Glucagon-like Peptide 1 Receptor Agonists on Obstructive Sleep Apnoea: A Scoping... Background: Obstructive sleep apnoea (OSA) and associated hypopnoea syndromes are chronic conditions of sleep-disordered breathing with significant sequelae if... glucagon like peptide 1 https://www.healthday.com/healthpro-news/mental-health/glucagon-like-peptide-1-receptor-agonists-may-be-treatment-for-alcohol-use-disorder Glucagon-Like Peptide-1 Receptor Agonists May Aid Alcohol Use Disorder Glucagon-like peptide-1 receptor agonists may be a potential novel treatment for alcohol use disorder. glucagon like peptide 1 receptor agonists alcohol use https://pmc.ncbi.nlm.nih.gov/articles/PMC4216654/ Cardiovascular effects of Glucagon-like peptide 1 (GLP-1) receptor agonists - PMC Patients with type 2 diabetes have a several-fold increased risk of developing cardiovascular disease when compared with nondiabetic controls. Myocardial... glucagon like peptide 1 receptor agonists cardiovascular effects https://pmc.ncbi.nlm.nih.gov/articles/PMC10761230/ Glucagon-Like Peptide-1 (GLP-1) during Ramadan: Narrative Review of the Published Literature - PMC Ramadan fasting, a religious practice observed by Muslims worldwide, involves abstaining from eating, drinking, smoking, and using oral medications from dawn... glucagon like peptide 1 https://pmc.ncbi.nlm.nih.gov/articles/PMC12322966/ Severe reflux oesophagitis caused by repeated vomiting due to glucagon-like peptide-1 receptor... glucagon like peptide 1 https://www.jci.org/articles/view/15595/figure/7 JCI - Glucagon-like peptide-1 receptor stimulation increases blood pressure and heart rate and... glucagon like peptide 1 https://www.jci.org/articles/view/194752 JCI - Signaling architecture of the glucagon-like peptide-1 receptor glucagon like peptide 1 of the jci signaling architecture https://pmc.ncbi.nlm.nih.gov/articles/PMC8961394/ Association of Glucagon-Like Peptide-1 Receptor Agonist Use With Risk of Gallbladder and Biliary... Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have been widely recommended for glucose control and cardiovascular risk reduction in patients with type... glucagon like peptide 1 https://pmc.ncbi.nlm.nih.gov/articles/PMC8796881/ Racial, Ethnic, and Socioeconomic Inequities in Glucagon-Like Peptide-1 Receptor Agonist Use Among... Are there inequities in glucagon-like peptide-1 receptor agonist (GLP-1 RA) use based on race, ethnicity, sex, and socioeconomic status among patients with... glucagon like peptide 1 https://www.jci.org/articles/view/15595/figure/5 JCI - Glucagon-like peptide-1 receptor stimulation increases blood pressure and heart rate and... glucagon like peptide 1 https://www.hanselman.com/blog/glucagonlike-peptide-1-137-converts-intestinal-epithelial-cells-into-insulinproducing-cells Glucagon-like peptide 1 (1-37) converts intestinal epithelial cells into insulin-producing cells. -... Diabetes WebLog: Just wanted to let everyone know about a brand-new research ... glucagon like peptide 1 intestinal epithelial cells https://pmc.ncbi.nlm.nih.gov/articles/PMC7911747/ Glucagon-Like Peptide-1 Receptor Agonists for Treatment of Nonalcoholic Fatty Liver Disease and... To assess the efficacy of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) for treatment of nonalcoholic fatty liver disease (NAFLD) or steatohepatitis... glucagon like peptide 1 https://pmc.ncbi.nlm.nih.gov/articles/PMC12411144/ Cost-Effectiveness of Obesity Treatments: Glucagon-Like Peptide-1 Receptor Agonists, Endoscopic... Obesity represents a major global health challenge, requiring interventions that are both effective and economically sustainable. This review examines the... glucagon like peptide 1 cost effectiveness https://pmc.ncbi.nlm.nih.gov/articles/PMC8613929/ The dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1)... Incretin hormones are peptides released in the intestine in response to the presence of nutrients in its lumen. The main incretins are glucagon-like peptide-1... glucagon like peptide 1 https://pmc.ncbi.nlm.nih.gov/articles/PMC12421399/ Glucagon-like peptide-1 receptor agonists: Evolution, gastrointestinal adverse effects, and future... Obesity is a global pandemic that has been threatening the worldwide population. It has been reported to be associated with an increase in the risk of chronic... glucagon like peptide 1 receptor agonists https://www.jci.org/articles/view/15595/figure/2 JCI - Glucagon-like peptide-1 receptor stimulation increases blood pressure and heart rate and... glucagon like peptide 1 https://pmc.ncbi.nlm.nih.gov/articles/PMC12780994/ The Beneficial Effects of Glucagon-Like Peptide-1 Agonists on Blood Pressure: A Comprehensive... Hypertension is a prominent cardiovascular risk factor, especially among patients with diabetes and obesity. Glucagon-like peptide-1 receptor agonists (GLP-1... glucagon like peptide 1 https://www.jci.org/articles/view/15595/figure/6 JCI - Glucagon-like peptide-1 receptor stimulation increases blood pressure and heart rate and... glucagon like peptide 1 https://pmc.ncbi.nlm.nih.gov/articles/PMC12048073/ A retrospective evaluation of glucagon-like peptide-1 receptor agonists in systemic lupus... Glucagon-like peptide-1 receptor agonists (GLP1-RA) are an emerging class of medications with demonstrated promise in improving cardiometabolic outcomes.... glucagon like peptide 1 https://www.spandidos-publications.com/10.3892/ijmm.2013.1252 Role of glucagon-like peptide-1 in the pathogenesis of experimental irritable bowel syndrome rat... International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease. glucagon like peptide 1 https://pmc.ncbi.nlm.nih.gov/articles/PMC10998705/ Glucagon-Like Peptide-1 Receptor Agonists and Thyroid Cancer: A Narrative Review - PMC Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are highly effective medications for the treatment of type 2 diabetes and obesity. Pharmacological... glucagon like peptide 1 https://www.mordorintelligence.com/industry-reports/latin-america-glucagon-like-peptide-1-agonists-market Latin America Glucagon-like Peptide-1 Agonists Market - GLP-1 - Size, Share & Analysis The Latin America Glucagon-like Peptide-1 (GLP-1) Agonists Market worth USD 2.91 billion in 2026 is growing at a CAGR of 8.24% to reach USD 4.33 billion by... glucagon like peptide 1 latin america https://pmc.ncbi.nlm.nih.gov/articles/PMC3594872/ Glucagon-like peptide 1 and appetite - PMC Glucagon-like peptide 1 (GLP-1) and GLP-1 analogs have received much recent attention due to the success of GLP-1 mimetics in treating type II diabetes... glucagon like peptide 1 appetite pmc https://pmc.ncbi.nlm.nih.gov/articles/PMC10775775/ Medicare formulary restrictions for glucagon-like peptide 1 receptor agonists and sodium glucose... Glucagon-like peptide 1 receptor agonists (GLP1-RAs) and sodium glucose cotransporter 2 inhibitors (SGLT2is) have proven benefits in patients with type 2... glucagon like peptide 1 https://pmc.ncbi.nlm.nih.gov/articles/PMC12765848/ Glucagon-like peptide-1 medicines in neurological and psychiatric disorders - PMC Glucagon-like peptide-1 (GLP-1) medicines are used for the treatment of type 2 diabetes (T2D) and obesity and reduce rates of cardiovascular disease, including... glucagon like peptide 1 psychiatric disorders medicines https://www.verifiedmarketresearch.com/product/asia-pacific-glucagon-like-peptide-1glp-1-agonists-market/ Asia Pacific Glucagon-Like Peptide-1(GLP-1) Agonists Market Report: Size, Growth, Trends & Forecast... Dec 22, 2025 - Asia Pacific Glucagon-Like Peptide-1(GLP-1) Agonists Market size is projected to reach USD 9.9 Billion by 2032, growing at a CAGR of 13.9% from 2026 to 2032... glucagon like peptide 1 https://pmc.ncbi.nlm.nih.gov/articles/PMC12664052/ All-cause mortality and cardiovascular outcomes with glucagon-like peptide-1 receptor agonists in... Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are a popular first-line treatment option in managing Type 2 Diabetes Mellitus (T2DM) with cardiovascular... glucagon like peptide 1 all cause mortality https://pmc.ncbi.nlm.nih.gov/articles/PMC9357557/ Clinical Impact of Semaglutide, a Glucagon-Like Peptide-1 Receptor Agonist, on Obesity Management:... Obesity and overweight pose a threat to health and are more common than undernutrition among adults. It is categorized by fat accumulation and a body mass... glucagon like peptide 1 https://pmc.ncbi.nlm.nih.gov/articles/PMC10371247/ The glucagon-like peptide-1 (GLP-1) analogue semaglutide reduces alcohol drinking and modulates... Growing evidence indicates that the glucagon-like peptide-1 (GLP-1) system is involved in the neurobiology of addictive behaviors, and GLP-1 analogues may be... glucagon like peptide 1 https://pmc.ncbi.nlm.nih.gov/articles/PMC12293269/ Glucagon-like Peptide-1 Receptor Agonists: A New Frontier in Treating Alcohol Use Disorder - PMC Background/Objectives: Glucagon-like peptide-1 receptor agonists (GLP-1RAs), which were originally developed for managing type 2 diabetes by enhancing insulin... glucagon like peptide 1